The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling.

Abstract:

:Glycyrrhizic acid is widely applied as a sweetener in food products and chewing tobacco. In addition, it is of clinical interest for possible treatment of chronic hepatitis C. In some highly exposed subjects, side effects such as hypertension and symptoms associated with electrolyte disturbances have been reported. To analyze the relationship between the pharmacokinetics of glycyrrhizic acid in its toxicity, the kinetics of glycyrrhizic acid and its biologically active metabolite glycyrrhetic acid were evaluated. Glycyrrhizic acid is mainly absorbed after presystemic hydrolysis as glycyrrhetic acid. Because glycyrrhetic acid is a 200-1000 times more potent inhibitor of 11-beta-hydroxysteroid dehydrogenase compared to glycyrrhizic acid, the kinetics of glycyrrhetic acid are relevant in a toxicological perspective. Once absorbed, glycyrrhetic acid is transported, mainly taken up into the liver by capacity-limited carriers, where it is metabolized into glucuronide and sulfate conjugates. These conjugates are transported efficiently into the bile. After outflow of the bile into the duodenum, the conjugates are hydrolyzed to glycyrrhetic acid by commensal bacteria; glycyrrhetic acid is subsequently reabsorbed, causing a pronounced delay in the terminal plasma clearance. Physiologically based pharmacokinetic modeling indicated that, in humans, the transit rate of gastrointestinal contents through the small and large intestines predominantly determines to what extent glycyrrhetic acid conjugates will be reabsorbed. This parameter, which can be estimated noninvasively, may serve as a useful risk estimator for glycyrrhizic-acid-induced adverse effects, because in subjects with prolonged gastrointestinal transit times, glycyrrhetic acid might accumulate after repeated intake.

journal_name

Drug Metab Rev

journal_title

Drug metabolism reviews

authors

Ploeger B,Mensinga T,Sips A,Seinen W,Meulenbelt J,DeJongh J

doi

10.1081/dmr-100104400

keywords:

subject

Has Abstract

pub_date

2001-05-01 00:00:00

pages

125-47

issue

2

eissn

0360-2532

issn

1097-9883

journal_volume

33

pub_type

杂志文章,评审
  • Drugs as CYP3A probes, inducers, and inhibitors.

    abstract::Human cytochrome P450 (CYP) 3A subfamily members (mainly CYP3A4 and CYP3A5) mediate the metabolism of approximately half all marketed drugs and thus play a critical role in the drug metabolism. A huge number of studies on CYP3A-mediated drug metabolism in humans have demonstrated that CYP3A activity exhibits marked et...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1080/03602530701690374

    authors: Liu YT,Hao HP,Liu CX,Wang GJ,Xie HG

    更新日期:2007-01-01 00:00:00

  • Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity.

    abstract::Hepatotoxicity is a serious problem during drug development and for the use of many established drugs. For example, acetaminophen overdose is currently the most frequent cause of acute liver failure in the United States and Great Britain. Evaluation of the mechanisms of drug-induced liver injury indicates that mitocho...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602532.2011.602688

    authors: Jaeschke H,McGill MR,Ramachandran A

    更新日期:2012-02-01 00:00:00

  • Nuclear receptors and endobiotics glucuronidation: the good, the bad, and the UGT.

    abstract::The recent progresses in molecular biology and pharmacology approaches allowed the characterization of a series of nuclear receptors (NRs) as efficient regulators of uridine diphosphate glucuronosyltransferase (UGT) genes activity. These regulatory processes ensure an optimized UGT expression in response to specific e...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602532.2012.751992

    authors: Bigo C,Caron S,Dallaire-Théroux A,Barbier O

    更新日期:2013-02-01 00:00:00

  • LC-MS-based metabolomics in drug metabolism.

    abstract::Xenobiotic metabolism, a ubiquitous natural response to foreign compounds, elicits initiating signals for many pathophysiological events. Currently, most widely used techniques for identifying xenobiotic metabolites and metabolic pathways are empirical and largely based on in vitro incubation assays and in vivo radiot...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1080/03602530701497804

    authors: Chen C,Gonzalez FJ,Idle JR

    更新日期:2007-01-01 00:00:00

  • Molecular and environmental causes of cancer.

    abstract::The multistep, clonal evolution model of cancer predicts fundamental mechanisms by which chemicals may influence the cancer process. These are illustrated by studies of the mechanisms of induction of carcinogenesis by estrogens and the inhibition of carcinogenesis by caloric restriction. ...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1081/dmr-100100567

    authors: Barrett JC

    更新日期:2000-05-01 00:00:00

  • NAT1 genotypic and phenotypic contribution to urinary bladder cancer risk: a systematic review and meta-analysis.

    abstract::N-acetyltransferase 1 (NAT1), a polymorphic Phase II enzyme, plays an essential role in metabolizing heterocyclic and aromatic amines, which are implicated in urinary bladder cancer (BCa). This systematic review investigates a possible association between the different NAT1 genetic polymorphisms and BCa risk. Medline,...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,meta分析,评审

    doi:10.1080/03602532.2017.1415928

    authors: Dhaini HR,El Hafi B,Khamis AM

    更新日期:2018-05-01 00:00:00

  • The biological actions of dehydroepiandrosterone involves multiple receptors.

    abstract::Dehydroepiandrosterone has been thought to have physiological functions other than as an androgen precursor. The previous studies performed have demonstrated a number of biological effects in rodents, such as amelioration of disease in diabetic, chemical carcinogenesis, and obesity models. To date, activation of the p...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1080/03602530600569877

    authors: Webb SJ,Geoghegan TE,Prough RA,Michael Miller KK

    更新日期:2006-01-01 00:00:00

  • Disposition of a series of tetrahydrocarbazoles.

    abstract::Cyclindole was extensively metabolized and eliminated primarily via the kidneys from most laboratory animals and man. Only in the dog was cyclindole a major urinary component. Cyclindole was metabolized by N-demethylation and/or hydroxylation. In studies utilizing radiolabeled drug, the primary urinary component was p...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602538008994027

    authors: Edelson J,Benziger DP

    更新日期:1980-01-01 00:00:00

  • PharmGKB: understanding the effects of individual genetic variants.

    abstract::The Pharmacogenetics and Pharmacogenomics Knowledge Base (PharmGKB: http://www.pharmgkb.org) is devoted to disseminating primary data and knowledge in pharmacogenetics and pharmacogenomics. We are annotating the genes that are most important for drug response and present this information in the form of Very Important ...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章

    doi:10.1080/03602530802413338

    authors: Sangkuhl K,Berlin DS,Altman RB,Klein TE

    更新日期:2008-01-01 00:00:00

  • Effect of cardiopulmonary bypass on cytochrome P450 enzyme activity: implications for pharmacotherapy.

    abstract::For patients undergoing cardiopulmonary bypass (CPB) during cardiac surgery, there are well-documented changes in the pharmacokinetics (PK) of commonly administered drugs. Although multiple factors potentially underpin these changes, there has been scant research attention on the impact of CPB to alter the activities ...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1080/03602532.2017.1417423

    authors: Adiraju SKS,Shekar K,Fraser JF,Smith MT,Ghassabian S

    更新日期:2018-05-01 00:00:00

  • Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolism.

    abstract::Voriconazole, a second-generation triazole frequently used for the prophylaxis and treatment of invasive fungal infections, undergoes complex metabolism mainly involving various (polymorphic) cytochrome P450 enzymes in humans. Although high inter- and intraindividual variability in voriconazole pharmacokinetics have b...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1080/03602532.2019.1632888

    authors: Schulz J,Kluwe F,Mikus G,Michelet R,Kloft C

    更新日期:2019-08-01 00:00:00

  • Mechanisms regulating human FMO3 transcription.

    abstract::Flavin-containing monooxygenases (FMOs) are important oxidative drug metabolizing enzymes. FMO3 is the primary human adult liver FMO enzyme, but is developmentally regulated. FMO3 promoter characterization using in vitro DNA binding assays with HepG2 cell and fetal and adult liver nuclear protein, as well as FMO3/repo...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章

    doi:10.1080/03602530701498612

    authors: Klick DE,Hines RN

    更新日期:2007-01-01 00:00:00

  • Allosteric modulators of cannabinoid receptor 1: developing compounds for improved specificity.

    abstract::The cannabinoid receptor 1 (CB1) is a G protein-coupled receptor (GPCR) that is located primarily in the central nervous system. CB1 is a therapeutic target which may impact pathways to mediate pain, neurodegenerative disorders, hunger, and drug-seeking behavior. Despite these benefits, development of orthosteric ther...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1080/03602532.2018.1428342

    authors: Dopart R,Lu D,Lichtman AH,Kendall DA

    更新日期:2018-02-01 00:00:00

  • Regulatory functions of glutathione S-transferase P1-1 unrelated to detoxification.

    abstract::Glutathione S-transferase P1-1 (GSTP) is one member of the family of GSTs and is ubiquitously expressed in human tissues. The literature is replete with reports of high levels of GSTP linked either with cancer incidence or drug resistance, and yet no entirely cogent explanation for these correlations exists. The catal...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602532.2011.552912

    authors: Tew KD,Townsend DM

    更新日期:2011-05-01 00:00:00

  • Mechanisms of cell-cycle checkpoints: at the crossroads of carcinogenesis and drug discovery.

    abstract::Human tumors arise from multiple genetic changes that gradually transform growth-limited cells into highly invasive cells that are unresponsive to growth controls. The genetic evolution of normal cells into cancer cells is largely determined by the fidelity of DNA replication, repair, and division. Cell-cycle arrest i...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1081/dmr-100102335

    authors: Flatt PM,Pietenpol JA

    更新日期:2000-08-01 00:00:00

  • Captopril: pharmacology, metabolism and disposition.

    abstract::By inhibiting ACE, captopril blocks the conversion of AI or AII and augments the effects of bradykinin both in vitro and in vivo. In rats, dogs, and monkeys with 2-kidney renal hypertension, orally administered captopril rapidly and markedly reduces blood pressure; this antihypertensive effect apparently occurs via a ...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602538409041080

    authors: Migdalof BH,Antonaccio MJ,McKinstry DN,Singhvi SM,Lan SJ,Egli P,Kripalani KJ

    更新日期:1984-01-01 00:00:00

  • On the mechanism of hepatocarcinogenesis of benzodiazepines: evidence that diazepam and oxazepam are CYP2B inducers in rats, and both CYP2B and CYP4A inducers in mice.

    abstract::The aim of this study was to evaluate diazepam and oxazepam as cytochrome P450 inducers at doses previously shown to cause liver tumors in mice but not rats. In rats, diazepam and oxazepam induced CYP2B, and were as effective as phenobarbital despite lacking phenobarbital's tumor-promoting effect in rats. In mice, dia...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章

    doi:10.1080/03602530600570081

    authors: Parkinson A,Leonard N,Draper A,Ogilvie BW

    更新日期:2006-01-01 00:00:00

  • Applications of surface-enhanced Raman scattering in advanced bio-medical technologies and diagnostics.

    abstract::In this review of the literature on surface-enhanced Raman scattering (SERS), we describe recent developments of this technique in the medical field. SERS has developed rapidly in the last few years as a result of the fascinating advancements in instrumentation and the ability to interpret complex Raman data using hig...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602532.2013.873451

    authors: Nima ZA,Biswas A,Bayer IS,Hardcastle FD,Perry D,Ghosh A,Dervishi E,Biris AS

    更新日期:2014-05-01 00:00:00

  • Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.

    abstract::Human CYP1A2 is one of the major CYPs in human liver and metabolizes a number of clinical drugs (e.g., clozapine, tacrine, tizanidine, and theophylline; n > 110), a number of procarcinogens (e.g., benzo[a]pyrene and aromatic amines), and several important endogenous compounds (e.g., steroids). CYP1A2 is subject to rev...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602530903286476

    authors: Zhou SF,Wang B,Yang LP,Liu JP

    更新日期:2010-05-01 00:00:00

  • Adverse pharmacokinetic interactions between illicit substances and clinical drugs.

    abstract::Adverse pharmacokinetic interactions between illicit substances and clinical drugs are of a significant health concern. Illicit substances are taken by healthy individuals as well as by patients with medical conditions such as mental illnesses, acquired immunodeficiency syndrome, diabetes mellitus and cancer. Many ind...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1080/03602532.2019.1697283

    authors: Abbott KL,Flannery PC,Gill KS,Boothe DM,Dhanasekaran M,Mani S,Pondugula SR

    更新日期:2020-02-01 00:00:00

  • N-oxidative transformation of free and N-substituted amine functions by cytochrome P450 as means of bioactivation and detoxication.

    abstract::Indirect evidence for the participation of cytochrome P450 (P450) in the microsomal N-oxygenation of primary and N-substituted amine functions is presented by studies employing diagnostic modifiers of the hemoprotein system as well as immunochemical approaches. Experiments with recombinant hemoproteins or isozymes pur...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1081/dmr-120005646

    authors: Hlavica P

    更新日期:2002-08-01 00:00:00

  • Novel pathways associated with quinone-induced stress in breast cancer cells.

    abstract::Hormone-dependent breast cancers that overexpress the ligand-binding nuclear transcription factor, estrogen receptor (ER), represent the most common form of breast epithelial malignancy. Exposure of breast epithelial cells to a redox-cycling and arylating quinone induces mitogen-activated protein kinase phosphorylatio...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1080/03602530600959391

    authors: Benz CC,Atsriku C,Yau C,Britton D,Schilling B,Gibson BW,Baldwin MA,Scott GK

    更新日期:2006-01-01 00:00:00

  • Role of single nucleotide polymorphisms in pharmacogenomics and their association with human diseases.

    abstract::Global statistical data shed light on an alarming trend that every year thousands of people die due to adverse drug reactions as each individual responds in a different way to the same drug. Pharmacogenomics has come up as a promising field in drug development and clinical medication in the past few decades. It has em...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602532.2015.1047027

    authors: Chaudhary R,Singh B,Kumar M,Gakhar SK,Saini AK,Parmar VS,Chhillar AK

    更新日期:2015-08-01 00:00:00

  • N-hydroxyarylamines.

    abstract::Aryl and heterocyclic amines are of particular interest because of their carcinogenicity. The N-hydroxy derivatives are formed by oxidation, usually by the cytochrome P450 (P450) enzymes and most often by P450 family 1. The mechanism of oxidation appears to resemble that of other P450 reactions. The N-hydroxy products...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1081/dmr-120005663

    authors: Guengerich FP

    更新日期:2002-08-01 00:00:00

  • Stereoselectivity of chiral drug transport: a focus on enantiomer-transporter interaction.

    abstract::Drug transporters and drug metabolism enzymes govern drug absorption, distribution, metabolism and elimination. Many literature works presenting important aspects related to stereochemistry of drug metabolism are available. However, there is very little literature on stereoselectivity of chiral drug transport and enan...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602532.2014.887094

    authors: Zhou Q,Yu LS,Zeng S

    更新日期:2014-08-01 00:00:00

  • Predictive models for human glucose-6-phosphate dehydrogenase deficiency.

    abstract::The present paper has discussed available test systems for determination of the response of G-6-PD-deficient human erythrocytes to environmental agents. The limitations and advantages of each model have been examined, and the results of research using each model have been presented. The future development of suitable ...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602538608998292

    authors: Horton HM,Calabrese EJ

    更新日期:1986-01-01 00:00:00

  • Pharmacology, drug efficacy, and the individual.

    abstract::The efficacy of drugs has to be demonstrated following the principal approach of statistical evaluation in controlled clinical trials. This scientifically and internationally accepted numerical approach has developed over the years to its importance, in contrast to the more pharmacologically attempt to extrapolate hum...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1081/dmr-200033500

    authors: Hildebrandt AG

    更新日期:2004-10-01 00:00:00

  • Quinone reductases multitasking in the metabolic world.

    abstract::The multiple functions of NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase) in the cell are reviewed. NQO1 has long been viewed as a chemoprotective enzyme involved in cellular defense against the electrophilic and oxidizing metabolites of xenobiotic quinones. It also participates in reduction of endogenous quino...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1081/dmr-200033465

    authors: Ross D

    更新日期:2004-10-01 00:00:00

  • Drug transporters: gatekeepers controlling access of xenobiotics to the cellular interior.

    abstract::In this paper, we evaluate methodologies and null mouse models used to study drug transporter function in vitro and in vivo. P-glycoprotein and MRP null mice have been used to examine many aspects of xenobiotic distribution and bioavailability. Their advantage over conventional models is that they allow the exclusion ...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1080/03602530802605040

    authors: Stanley LA,Horsburgh BC,Ross J,Scheer N,Wolf CR

    更新日期:2009-01-01 00:00:00

  • Covalent binding of xenobiotics to specific proteins in the liver.

    abstract::Chemicals that cause toxicity though a direct mechanism, such as acetaminophen, covalently bind to a select group of proteins prior to the development of toxicity, and these proteins may be important in the initiation of the events that lead to the hepatotoxicity. Disruption of the cell is measured by release of intra...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602539709037572

    authors: Pumford NR,Halmes NC,Hinson JA

    更新日期:1997-02-01 00:00:00